Onconova Therapeutics (NASDAQ:ONTX) Research Coverage Starte

StockNews.com assumed coverage on shares of Onconova Therapeutics (NASDAQ:ONTX – Get Rating) in a research report released on Monday. The firm issued a hold rating on the biopharmaceutical company’s stock. Separately, HC Wainwright upgraded Onconova Therapeutics from a neutral rating to a buy rating and set a $11.00 price objective on the stock in a […]

Related Keywords

Ramesh Kumar , E Premkumar Reddy , Millennium Management , Beacon Pointe Advisors , Onconova Therapeutics Inc , Renaissance Technologies , Onconova Therapeutics Company Profile , Vanguard Group Inc , Onconova Therapeutics , Get Rating , Pointe Advisors , Vanguard Group , Onconova Therapeutics Daily , Nasdaq Ontx , Contx , Medical , Initiated Coverage , Stocknews Com ,